Skip to main content
Home

Top menu InfoLep

  • About InfoLep


Main navigation

  • Home
  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day 2023
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Antimicrobial resistance in leprosy
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Publications
  • Practical materials
  • Organizations

Top menu - mobile infoLep

  • About InfoLep

Refine your results

Refine your results


Selected filters

  • Reset filters
  • Trachoma
  • NTD NGDO Network member
  • Partnership
  • Government department/organization
  • InfoNTD Partner
  • Information, library and publishing
  • People's organization
  • Professional organization
  • Funding & Grants

NTD

  • Onchocerciasis (9)
  • Lymphatic filariasis (Elephantiasis) (8)
  • Schistosomiasis (7)
  • Soil-transmitted helminths (6)
  • Leishmaniasis (3)
  • Buruli Ulcer (2)
  • Chagas disease (American trypanosomiasis) (2)
  • Dracunculiasis (guinea-worm disease) (2)
  • Leprosy (Hansen disease) (2)
  • Yaws (2)
  • Human African trypanosomiasis (HAT) - Sleeping sickness (1)
  • Mycetoma (1)
  • Podoconiosis (1)
  • Zika virus (1)
  • (-) Trachoma (12)

Country

  • United States (4)
  • Australia (1)
  • France (1)
  • Nigeria (1)
  • Switzerland (1)
  • United Kingdom (1)

Type of Organization

  • NGO (12)
  • Academic/research institution (2)
  • (-) NTD NGDO Network member (7)
  • (-) Partnership (4)
  • (-) Government department/organization (1)
  • (-) InfoNTD Partner (1)
 
12 items
Organization

DNTDs - German Network Against Neglected Tropical Diseases

Organization

ENVISION

Organization

ESPEN - Expanded Special Project for Elimination of Neglected Tropical Diseases

Organization

Fred Hollows Foundation

Organization

HKI - Helen Keller International

Organization

ITI - International Trachoma Initiative

Organization

MITOSATH - Mission to Safe the Helpless .

Organization

OPC - Organisation pour la Prévention de la Cécité / Organisation for the Prevention of Blindness.

Organization

ORBIS - Transforming Lives Through Access to Quality Eye Health.

Organization

Sightsavers

Organization

The END Fund : Ending Neglected Diseases.

Organization

WHO - World Health Organization - Neglected Tropical Diseases.

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications
  • Organizations

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

  • infontd

© 2023 InfoNTD